Syneos Health Reports Fourth Quarter and Full Year 2021 Results
17 févr. 2022 06h10 HE
|
Syneos Health, Inc.
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
Syneos Health Appoints Two New Independent Directors
18 janv. 2022 06h16 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
11 janv. 2022 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
16 nov. 2021 07h53 HE
|
Takeda Pharmaceuticals
Dubai, United Arab Emirates, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Recognizing that climate change poses a risk to human health, including the spread of infectious diseases, Takeda has made...